Your funds, side by side
The lines these funds hold in common, and the companies you own through them. Weights are the ones each document states, with no currency conversion.
- iShares U.S. Pharmaceuticals ETF iShares Trust · 56 lines · as of Mar 31, 2026 · 100.0 %
Add a second fund to see what the two hold in common.
The companies you hold through them
A company's weight in the portfolio is its weight inside each fund, times that fund's share of the portfolio. With no amounts given, the funds weigh the same.
| Holding | iShares U.S. Pharmaceuticals ETF |
|---|---|
| Johnson & Johnson | 23.03 % |
| Eli Lilly & Co | 21.06 % |
| Merck & Co Inc | 4.74 % |
| Pfizer Inc | 4.71 % |
| Royalty Pharma PLC | 4.70 % |
| Bristol-Myers Squibb Co | 4.63 % |
| Zoetis Inc | 4.52 % |
| Viatris Inc | 4.35 % |
| Elanco Animal Health Inc | 3.32 % |
| Jazz Pharmaceuticals PLC | 3.21 % |
| Axsome Therapeutics Inc | 2.00 % |
| Terns Pharmaceuticals Inc | 1.27 % |
| Ligand Pharmaceuticals Inc | 1.10 % |
| Indivior Pharmaceuticals Inc | 1.06 % |
| Corcept Therapeutics Inc | 1.05 % |
| Crinetics Pharmaceuticals Inc | 1.04 % |
| Supernus Pharmaceuticals Inc | 0.83 % |
| Prestige Consumer Healthcare Inc | 0.78 % |
| Tarsus Pharmaceuticals Inc | 0.77 % |
| Liquidia Corp | 0.72 % |
| Edgewise Therapeutics Inc | 0.65 % |
| Amneal Pharmaceuticals Inc | 0.59 % |
| Nektar Therapeutics | 0.56 % |
| Definium Therapeutics Inc | 0.52 % |
| Alumis Inc | 0.50 % |
| Enliven Therapeutics Inc | 0.49 % |
| Innoviva Inc | 0.46 % |
| Organon & Co | 0.44 % |
| Perrigo Co PLC | 0.41 % |
| Ocular Therapeutix Inc | 0.41 % |
1 funds, 56 lines read.